Drug intelligence / Profile preview

Achicobal Forte

Development stage: Unknown
Lead developer: Achilles Healthcare
Modality: Small Molecules
Administration: Oral, Parenteral

Overview

**Achicobal Forte** is an Achilles Healthcare combination nutraceutical product containing methylcobalamin, folic acid, alpha lipoic acid, and pyridoxine. It combines B-vitamin supplementation with alpha lipoic acid, an antioxidant cofactor, to support vitamin-dependent metabolic and neurologic functions. The supplied Achilles Healthcare pipeline information identifies the product and its four active ingredients but does not specify a therapeutic indication, dosage form, route, or release formulation.

Brand names: Achicobal Forte
Other names: alpha lipoic acid + folic acid + methylcobalamin + pyridoxinemethylcobalamin + folic acid + alpha lipoic acid + pyridoxine

Beyond the preview

Go deeper on Achicobal Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Achicobal Forte.

Explore the full profile